Anna L. Blobaum

3.4k citations

97 papers · 2.6k indexed · h-index 29

Molecular Biology top 10%
Cellular and Molecular Neuroscience top 2%
Organic Chemistry top 5%
Pharmacology top 2%
Pharmacology top 2%

Co-authors: Lawrence J. Marnett Craig W. Lindsley P. Jeffrey Conn Colleen M. Niswender Carrie K. Jones J. Scott Daniels Corey R. Hopkins Alice L. Rodriguez
Topics: Neuroscience and Neuropharmacology Research (55 papers)Receptor Mechanisms and Signaling (42 papers)Pharmacological Receptor Mechanisms and Effects (20 papers)
Cited by: Cellular and Molecular Neuroscience Pharmacology
Journals: Journal of Biological Chemistry Biochemistry Cancer Research
Partner nations: United States Germany Spain

In The Last Decade

Anna L. Blobaum

97 papers receiving 2.5k citations

Peers

Countries citing papers authored by Anna L. Blobaum

Since Specialization

Citations

This map shows the geographic impact of Anna L. Blobaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna L. Blobaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna L. Blobaum more than expected).

Fields of papers citing papers by Anna L. Blobaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna L. Blobaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna L. Blobaum. The network helps show where Anna L. Blobaum may publish in the future.

Co-authorship network of co-authors of Anna L. Blobaum

This figure shows the co-authorship network connecting the top 25 collaborators of Anna L. Blobaum. A scholar is included among the top collaborators of Anna L. Blobaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna L. Blobaum. Anna L. Blobaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of VU6007496: Challenges in the Development of an M₁ Positive Allosteric Modulator Backup Candidate 2024 ·ACS Chemical Neuroscience ·Julie L. Engers,(unknown),(unknown),(unknown),Aaron M. Bender,Jonathan W. Dickerson,Weimin Peng,(unknown),Hyekyung P. Cho,Alice L. Rodriguez,Colleen M. Niswender,Sean P. Moran,Zixiu Xiang,Anna L. Blobaum,Olivier Boutaud,(unknown),Darren W. Engers,P. Jeffrey Conn,Craig W. Lindsley	3
2	Development and profiling of mGlu7 NAMs with a range of saturable inhibition of agonist responses in vitro 2022 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Alice L. Rodriguez,(unknown),Mabel Seto,(unknown),Anna L. Blobaum,Sichen Chang,Craig W. Lindsley,Colleen M. Niswender	2
3	Discovery and optimization of a novel CNS penetrant series of mGlu4 PAMs based on a 1,4-thiazepane core with in vivo efficacy in a preclinical Parkinsonian model 2021 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Jonathan W. Dickerson,(unknown),Alice L. Rodriguez,Anna L. Blobaum,Olivier Boutaud,(unknown),Colleen M. Niswender,P. Jeffrey Conn,Craig W. Lindsley	5
4	Synthesis and SAR of a series of mGlu7 NAMs based on an ethyl-8-methoxy-4-(4-phenylpiperazin-1-yl)quinoline carboxylate core 2020 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Paul K. Spearing,(unknown),(unknown),Alice L. Rodriguez,Anna L. Blobaum,P. Jeffrey Conn,Colleen M. Niswender,Craig W. Lindsley	8
5	Surveying heterocycles as amide bioisosteres within a series of mGlu7 NAMs: Discovery of VU6019278 2019 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),(unknown),Alice L. Rodriguez,Darren W. Engers,Anna L. Blobaum,P. Jeffrey Conn,Colleen M. Niswender,Craig W. Lindsley	14
6	Structure-Activity Relationships, Pharmacokinetics, and Pharmacodynamics of the Kir6.2/SUR1-Specific Channel Opener VU0071063 2019 ·Journal of Pharmacology and Experimental Therapeutics ·Sujay V. Kharade,Juan V. Sanchez‐Andrés,(unknown),Elaine L. Shelton,Anna L. Blobaum,Darren W. Engers,(unknown),Prasanna K. Dadi,Louise Lantier,David A. Jacobson,Craig W. Lindsley,Jerod S. Denton	13
7	Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators 2018 ·Molecular Psychiatry ·Samantha E. Yohn,Daniel J. Foster,Dan P. Covey,Mark S. Moehle,(unknown),Pedro M. García-Barrantes,Hyekyung P. Cho,Michael Bubser,Anna L. Blobaum,Max E. Joffe,Joseph F. Cheer,Carrie K. Jones,Craig W. Lindsley,P. Jeffrey Conn	39
8	A Novel M ₁ PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic Toxicity 2018 ·ACS Chemical Neuroscience ·Jerri M. Rook,(unknown),Hyekyung P. Cho,Pedro M. García-Barrantes,Sean P. Moran,James Maksymetz,Kellie D. Nance,Jonathan W. Dickerson,(unknown),Sichen Chang,Joel M. Harp,Anna L. Blobaum,Colleen M. Niswender,Carrie K. Jones,Shaun R. Stauffer,P. Jeffrey Conn,Craig W. Lindsley	45
9	Discovery of 4-alkoxy-6-methylpicolinamide negative allosteric modulators of metabotropic glutamate receptor subtype 5 2018 ·Bioorganic & Medicinal Chemistry Letters ·Andrew S. Felts,(unknown),(unknown),Alice L. Rodriguez,Ryan D. Morrison,J. Scott Daniels,Anna L. Blobaum,Colleen M. Niswender,Carrie K. Jones,P. Jeffrey Conn,Kyle A. Emmitte,Craig W. Lindsley	4
10	mGlu ₇ potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndrome 2017 ·Science Translational Medicine ·Rocco G. Gogliotti,(unknown),Nicole M. Fisher,J. Paige Adams,Rocio Zamorano,Adam G. Walker,Anna L. Blobaum,Darren W. Engers,Corey R. Hopkins,J. Scott Daniels,Carrie K. Jones,Craig W. Lindsley,Zixiu Xiang,P. Jeffrey Conn,Colleen M. Niswender	63
11	Synthesis and characterization of a series of chiral alkoxymethyl morpholine analogs as dopamine receptor 4 (D4R) antagonists 2016 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),(unknown),(unknown),Kayla J. Temple,(unknown),Anna L. Blobaum,Craig W. Lindsley,Corey R. Hopkins	21
12	Re-exploration of the mGlu1 PAM Ro 07-11401 scaffold: Discovery of analogs with improved CNS penetration despite steep SAR 2016 ·Bioorganic & Medicinal Chemistry Letters ·Pedro M. García-Barrantes,Hyekyung P. Cho,(unknown),Anna L. Blobaum,Colleen M. Niswender,P. Jeffrey Conn,Craig W. Lindsley	6
13	Identification of the minimum PAR4 inhibitor pharmacophore and optimization of a series of 2-methoxy-6-arylimidazo[2,1-b][1,3,4]thiadiazoles 2016 ·Bioorganic & Medicinal Chemistry Letters ·Kayla J. Temple,Matthew T. Duvernay,(unknown),Anna L. Blobaum,Shaun R. Stauffer,Heidi E. Hamm,Craig W. Lindsley	6
14	Lead optimization of the VU0486321 series of mGlu1 PAMs. Part 3. Engineering plasma stability by discovery and optimization of isoindolinone analogs 2016 ·Bioorganic & Medicinal Chemistry Letters ·Pedro M. García-Barrantes,Hyekyung P. Cho,Anna L. Blobaum,Colleen M. Niswender,P. Jeffrey Conn,Craig W. Lindsley	10
15	Discovery, characterization and biological evaluation of a novel (R)-4,4-difluoropiperidine scaffold as dopamine receptor 4 (D4R) antagonists 2016 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Kayla J. Temple,(unknown),Joel M. Harp,Anna L. Blobaum,Craig W. Lindsley,Corey R. Hopkins	14
16	Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety 2013 ·Bioorganic & Medicinal Chemistry Letters ·Andrew S. Felts,Alice L. Rodriguez,Ryan D. Morrison,Daryl F. Venable,Jason Manka,(unknown),Anna L. Blobaum,Frank W. Byers,J. Scott Daniels,Colleen M. Niswender,Carrie K. Jones,P. Jeffrey Conn,Craig W. Lindsley,Kyle A. Emmitte	27
17	Octahydropyrrolo[3,4-c]pyrrole negative allosteric modulators of mGlu1 2013 ·Bioorganic & Medicinal Chemistry Letters ·Jason Manka,Alice L. Rodriguez,Ryan D. Morrison,Daryl F. Venable,Hyekyung P. Cho,Anna L. Blobaum,J. Scott Daniels,Colleen M. Niswender,P. Jeffrey Conn,Craig W. Lindsley,Kyle A. Emmitte	9
18	The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson’s Disease 2011 ·Journal of Pharmacology and Experimental Therapeutics ·Carrie K. Jones,Michael Bubser,Analisa D. Thompson,Jonathan W. Dickerson,N. Turle-Lorenzo,Marianne Amalric,Anna L. Blobaum,Thomas M. Bridges,Ryan D. Morrison,Satyawan Jadhav,Darren W. Engers,(unknown),(unknown),J. Scott Daniels,Craig W. Lindsley,Corey R. Hopkins,P. Jeffrey Conn,Colleen M. Niswender	81
19	Selective Visualization of Cyclooxygenase-2 in Inflammation and Cancer by Targeted Fluorescent Imaging Agents 2010 ·Cancer Research ·Md. Jashim Uddin,Brenda C. Crews,Anna L. Blobaum,Philip J. Kingsley,D. Lee Gorden,J. Oliver McIntyre,Lynn M. Matrisian,Kotha Subbaramaiah,Andrew J. Dannenberg,David W. Piston,Lawrence J. Marnett	151
20	MECHANISM-BASED INACTIVATION AND REVERSIBILITY: IS THERE A NEW TREND IN THE INACTIVATION OF CYTOCHROME P450 ENZYMES? 2005 ·Drug Metabolism and Disposition ·Anna L. Blobaum	27

About Anna L. Blobaum

Anna L. Blobaum is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology, having authored 97 papers that have together received 2.6k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (55 papers), Receptor Mechanisms and Signaling (42 papers) and Pharmacological Receptor Mechanisms and Effects (20 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (888 citations), Pharmacology (579 citations) and Pharmacology (217 citations). Anna L. Blobaum has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Lawrence J. Marnett, Craig W. Lindsley, P. Jeffrey Conn, Colleen M. Niswender, Carrie K. Jones, J. Scott Daniels, Corey R. Hopkins, Alice L. Rodriguez, Brenda C. Crews and Darren W. Engers. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact